SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
53 hedge funds and large institutions have $33.5M invested in Syros Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-6
Holders Change %
-10.17%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
12
Reduced
7
Closed
10
Calls
$828K
Puts
$1K
Net Calls
+$827K
Net Calls Change
+$128K
Top Buyers
| 1 |
APM
1
Avidity Partners Management
Dallas,
Texas
|
$4.61M |
| 2 |
DMKJ
2
David M. Knott Jr
|
$303K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$409K |
| 4 |
4
BlackRock
New York
|
$665K |
| 5 |
SC
5
Shay Capital
New York
|
$83.2K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FFA
51
Farther Finance Advisors
San Francisco,
California
| $63 | – | – | – |
|
|
CPA
52
Cowen Prime Advisors
New York
| $41 | – | – | – |
|
|
ABG
53
Ally Bridge Group
New York
| – | -$665K | -249,126 | Closed |
|
54
Marshall Wace
London,
United Kingdom
| – | -$81.6K | -30,551 | Closed |
|
55
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$52.4K | -19,633 | Closed |
|
|
CGL
56
Clarius Group LLC
Seattle,
Washington
| – | -$49.7K | -18,620 | Closed |
|
|
PCM
57
Prelude Capital Management
New York
| – | -$39.8K | -14,899 | Closed |
|
58
Acadian Asset Management
Boston,
Massachusetts
| – | -$34K | -12,776 | Closed |
|
|
TRCT
59
Tower Research Capital (TRC)
New York
| – | -$18K | -6,584 | Closed |
|
|
TCWA
60
Ten Capital Wealth Advisors
Spokane,
Washington
| – | -$585 | -219 | Closed |
|
|
NA
61
NewEdge Advisors
New Orleans,
Louisiana
| – | -$40 | -15 | Closed |
|